Convatec Group PLC

Major Shareholding Notification • Jun 9, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6826H

ConvaTec Group PLC

09 June 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii			CONVATEC GROUP PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		NORDIC CAPITAL VI LIMITED NORDIC CAPITAL VII LIMITED
4. Full name of shareholder(s)  (if different from 3.):iv		CIDRON HEALTHCARE TOPCO LIMITED CIDRON HEALTHCARE CO-INVEST LIMITED CIDRON HEALTHCARE CO-INVEST II LIMITED
5. Date of the transaction and date on which the threshold is crossed or reached: v		8 JUNE 2017
6. Date on which issuer notified:		9 JUNE 2017
7. Threshold(s) that is/are crossed or reached: vi, vii		Below 8%

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights				% of  voting rights x
Direct		Direct xi		Indirect xii		Direct			Indirect
ORDINARY SHARES OF £0.10 EACH	314,158,828			314,158,828			143,158,828		N/A		143,158,828	N/A				7.34%
GB00BD3VFW73
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date xiii			Exercise/ Conversion Period xiv				Number of voting rights that may be acquired if the instrument is exercised/ converted.					% of voting rights
N/A
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price			Expiration date xvii			Exercise/ Conversion period xviii	Number of voting rights instrument refers to					% of voting rights xix, xx
N/A														Nominal		Delta
Total (A+B+C)
Number of voting rights									Percentage of voting rights
143,158,828									7.34%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Nordic Capital VI Limited is the General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. (Fund VI) and is responsible for managing Fund VI. Nordic Capital VII Limited is the General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. (Fund VII) and is responsible for managing Fund VII. Fund VI and Fund VII hold shares in Cidron Healthcare Topco Limited (Topco). Topco in turn holds one management share in each of Cidron Healthcare Co-invest Limited and Cidron Healthcare Co-invest II Limited.
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	This disclosure has been calculated based on an issued share capital of 1,951,472,651 shares as disclosed by ConvaTec Group Plc in its AGM results announcement dated 11 May 2017.
14. Contact name:	LYNDA ELLIOTT
15. Contact telephone number:	+ 44 1534 605105

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAEKNELLXEFF